Zevra Therapeutics, Inc.ZVRANASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank100
3Y CAGR+187.7%
5Y CAGR+2.4%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+187.7%/yr
vs -53.4%/yr prior
5Y CAGR
+2.4%/yr
Recent acceleration
Acceleration
+241.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.98M | +8.5% |
| 2024 | $7.35M | +389.7% |
| 2023 | $1.50M | +348.1% |
| 2022 | $335000.00 | -10.9% |
| 2021 | $376000.00 | -94.7% |
| 2020 | $7.09M | +8.8% |
| 2019 | $6.51M | -8.1% |
| 2018 | $7.09M | -3.4% |
| 2017 | $7.34M | +2.9% |
| 2016 | $7.13M | - |